USP9Y and prostate carcinoma: The lncRNA TTTY15 is highly expressed on the Y chromosome, and in experiments to confirm whether TTTY15 affects the phenotype of prostate cancer cells, the successful knockdown of TTTY15 using the CRISPR/Cas9 method resulted in the reduced proliferation and migration of prostate cancer cells [178].